Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, for early puberty, as part of transgender hormone therapy, or to perform chemical castration of violent sex offenders. It is given by injection into a muscle or under the skin.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Leuprorelin. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
treatment testosterone use used lupron hormone puberty prostate cancer approved may fda injection effects also side drug gnrh leuprolide agonist
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Leuprorelin | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Leuprorelin | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Leuprorelin | ATC code | L02AE02 (WHO) | 1.00 | infobox |
| Leuprorelin | CAS Number | 53714-56-0 Y 74381-53-6 (acetate) | 1.00 | infobox |
| Leuprorelin | ChEMBL | ChEMBL1201199 N | 1.00 | infobox |
| Leuprorelin | ChemSpider | 571356 N | 1.00 | infobox |
| Leuprorelin | CompTox Dashboard (EPA) | DTXSID50872411 | 1.00 | infobox |
| Leuprorelin | Drug class | GnRH analogue; GnRH agonist; Antigonadotropin | 1.00 | infobox |
| Leuprorelin | DrugBank | DB00007 Y | 1.00 | infobox |
| Leuprorelin | ECHA InfoCard | 100.161.466 | 1.00 | infobox |
| Leuprorelin | Elimination half-life | 3 hours | 1.00 | infobox |
| Leuprorelin | Excretion | Kidney | 1.00 | infobox |
| Leuprorelin | Formula | C59H84N16O12 | 1.00 | infobox |
| Leuprorelin | IUPHAR/BPS | 1175 | 1.00 | infobox |
| Leuprorelin | KEGG | D08113 Y | 1.00 | infobox |
| Leuprorelin | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Leuprorelin | Legal status | CA: ℞-only | 1.00 | infobox |
| Leuprorelin | Legal status | US: ℞-only | 1.00 | infobox |
| Leuprorelin | Legal status | EU: Rx-only | 1.00 | infobox |
| Leuprorelin | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Leuprorelin | License data | US DailyMed: Leuprolide | 1.00 | infobox |
| Leuprorelin | MedlinePlus | a685040 | 1.00 | infobox |
| Leuprorelin | Molar mass | 1209.421 g·mol−1 | 1.00 | infobox |
| Leuprorelin | Other names | leuprolide, leuprolidine, A-43818, Abbott-43818, DC-2-269, TAP-144 | 1.00 | infobox |
| Leuprorelin | Pregnancy category | AU: D | 1.00 | infobox |
| Leuprorelin | PubChem CID | 657181 | 1.00 | infobox |
| Leuprorelin | Routes of administration | implant, subcutaneous, intramuscular | 1.00 | infobox |
| Leuprorelin | Trade names | Lupron, Eligard, Lucrin, Lupaneta, others | 1.00 | infobox |
| Leuprorelin | UNII | EFY6W0M8TG | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.